SIM
STRO icon

Spark Investment Management’s Sutro Biopharma STRO Stock Holding History

Spark Investment Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,459
Closed -$148K – 244
2020
Q1 		$148K Sell
1,459
-401
-22% -$42.1K 0.08% 254
2019
Q4 		$204K Buy
+1,860
New +$192K 0.02% 460
2019
Q3 		– Sell
-1,410
Closed -$160K – 509
2019
Q2 		$160K Sell
1,410
-70
-5% -$7.71K 0.01% 479
2019
Q1 		$168K Buy
+1,480
New +$154K 0.01% 523

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Spark Investment Management's STRO Position: Q2 2020 in Review

Spark Investment Management sold out of Sutro Biopharma (STRO) in Q2 2020, closing a stake of 1,459 shares — an estimated $148K sold.

Spark Investment Management first reported a position in STRO in Q1 2019 and held it in 4 quarters. The position peaked at $204K in Q4 2019. 80 funds tracked by Wall St. Rank hold STRO as of Q2 2020.

  • Spark Investment Management reported no remaining Sutro Biopharma position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 1,459 Sutro Biopharma shares in Q2 2020, an estimated $148K.
  • Spark Investment Management first reported a position in Sutro Biopharma in Q1 2019 and held it in 4 quarters.
  • Spark Investment Management's Sutro Biopharma position peaked at $204K in Q4 2019.
  • 80 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.